Biomedical engineers at Duke University have developed an AI platform that autonomously compares molecules and learns from their variations to anticipate property differences critical to discovering new pharmaceuticals. The platform provides researchers with a more accurate and efficient tool to help design therapeutics and other chemicals with useful properties.
The research was published on October 27 in the Journal of Cheminformatics.
Machine learning algorithms are increasingly used to study and predict the biological, chemical and physical properties of small molecules used in drug development and other material design tasks. These tools can help researchers understand the key “ADMET” properties of a molecule—how it’s absorbed, distributed, metabolized, excreted and its toxicity within the body. By understanding these different properties, researchers can identify molecules to develop new therapeutics that are safer and